Chapter 817 431: Secrets Hidden in the Depths of the World (Part 3)

To hold a wedding in such a luxurious and tasteful environment while receiving sweet blessings from relatives and friends, the happiness index is absolutely off the charts.

"Honey, take a picture of me here... No, wait, hasn't the blooming season for double lotus passed? Why are they still blooming so vigorously?"

"Such a fuss about nothing, what's a month or two past the blooming season? As long as you're willing to spend the money, even in the coldest winter, you can have any flowers you want in the pond."

The guests came and went, most of them well-dressed, exuding an extraordinary aura. Men, women, and children were either taking photos as mementos or chatting in the guest area.

For this wedding, Old Li and Old Yu didn't notify their relatives and friends; only the two of them personally attended. So everyone present was invited by the Huang family, including but not limited to the relatives and friends of Mr. and Mrs. Huang, Hezhi's partners, and bosses or leaders in the pharmaceutical industry.

These people were seated at different tables depending on their identity or rank, and the table in the second row was currently the liveliest one.

"Dean Sun, have you seen Hezhi's recent clinical trial report on the new drug?"

"Yes, it's a big news in the industry, how could I not know? But the descriptions seem a bit exaggerated, I'm hesitant to believe it, it's just in the trial phase... However, investors seem to have a lot of faith, Hezhi's stock price has soared like crazy these days, the market value is about to break 40 billion. Just with this one report, the stock price rose nearly 40%, impressive indeed."

"...Hehe."

The people at the table exchanged knowing smiles, without saying much.

Almost 80% of the domestic drug clinical data is 'untrue', sometimes it's deliberate for profit, sometimes accidental.

Because the patient groups during the clinical trial phase are not only very small, but also selected through various exclusions, making them 'cleaner' than real-world diagnosis patients, and the drug's cure rate is higher. But once it hits the market, with more users, the drug's matching rate decreases, and the cure data naturally drops compared to the clinical trials.

But the distance between "deliberate" and "accidental" is quite ambiguous, so many listed pharmaceutical companies will issue impressive data reports during the new drug trial phase to stimulate stock prices and boost investor confidence. As for a few years later, if the drug doesn't live up to expectations? That's a matter of probability, not important!

The people at the table were seasoned, clearly understanding the twists and turns, but this time with Hezhi, it was excessively fabricated, causing quite a stir in the industry.

Dean Sun adjusted his glasses, jokingly said, "I heard that today's bride was fully responsible for this project, seems like Old Huang intends to groom his daughter. It's a good choice, even if the drug performs only a third as well as the report suggests, Miss Huang surpassing her predecessor may win a Galen Award or a Nobel... If it doesn't even meet a third, her capital operation skills in Hezhi could earn her a Best Management Award!"

"Haha, is it awarded jointly by the Drug Administration and the Securities Regulatory Commission?"

Someone half-jokingly, half-sarcastically said, and the atmosphere instantly cooled down. After all, most of the attendees had good relationships with the Huang family, although there were some who put on a good face while having conflicts in private, at this happy occasion, most felt a bit uncomfortable hearing this, so someone immediately retorted.

"Jokes should not be made carelessly, I've also read the data report, and regarding the new compound reaction mentioned, I've done related research previously, it seems quite justified."

An elderly gentleman in his sixties or seventies with gray hair slowly said, "Just for this point, I believe the deviation in the report won't be that significant... Besides, the Drug Administration isn't entirely incompetent, has it been two weeks since the report was released? If it hugely deviated from reality, they would've addressed it by now."

"Professor Zhou, could you elaborate? I didn't quite understand the concept of 'new P-a gene molecule' mentioned in the report."

Professor Zhou slightly shook his head, "I'm also somewhat unclear, I want to ask Chairman Huang about it later, just not sure if it'll be convenient for him to explain. By the way, where is he, he was here just now, but I can't see him now?"

"Their entire family and the groom are greeting guests."

The person next to him pointed towards the entrance, "The head of Fangda Pharmaceutical is here."

By the floral archway, Huang Jianzhong, Gina, along with their sons Huang Xing'an and Huang Haoye, and Li Peifeng, were warmly greeting a mother-daughter pair, the whole family showing the Huang family's significant regard for them.

Zheng Ling, president of Fangda Pharmaceutical Group, overseeing more than twenty pharmaceutical companies, builder of a billion-dollar pharmaceutical empire, is a top-tier figure in the domestic pharmaceutical industry, backed by the Xie family of Chinese nobility, making her undoubtedly a heavyweight guest at this wedding.

Now nearing sixty, although Zheng Ling's face bears the marks of time, her hair is neatly styled in a short black cut, dressed in a light blue suit, exuding a confident and gentle woman of strength demeanor in her every gesture.

Her daughter, Xie Lingyun, chairman of Dongguo Biological Pharmaceutical's board of directors, this fourth-generation rich who just turned thirty, is youthful and attractive, with long flowing hair, wearing a pink long dress, elegant and poised.

"It's her."

Professor Zhou, with a focused gaze at Zheng Ling before the entrance, took a deep breath, hesitantly asked, "Is she the rumored one with 'x-ray vision'?"

"Yes."

Suddenly, Dean Sun spoke up, "Do you think there's any truth to this supernatural ability?"